戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y, lung function, and airway responsiveness (school age).
2 and asthma were collected when children were school age.
3 ne therapy is effective and safe into middle school age.
4 airway inflammation in asthmatic children at school age.
5 een specific modes of delivery and asthma at school age.
6 total IgE level or allergen sensitization at school age.
7 epression symptoms underwent neuroimaging at school age.
8             One patient had seizures only at school age.
9  age with cognitive and physical outcomes at school age.
10 y long-term benefit for visual processing at school age.
11 h the development of allergic diseases up to school age.
12 fe on the prevalence of allergic diseases at school age.
13 tein content reduces BMI and obesity risk at school age.
14 hology was examined in relation to asthma at school age.
15 children with family history of allergies at school age.
16 y inflammation, is associated with asthma at school age.
17  (ADHD) and impairment between preschool and school age.
18 erent respiratory/allergic phenotypes before school age.
19 lung volume growth in children of elementary-school age.
20 ween those who did or did not have asthma at school age.
21 ence the development of AD, asthma and AR at school age.
22  play in children's cognitive development at school age.
23 nt potential biomarkers of risk of asthma by school age.
24 ared to nonallergic children from infancy to school age.
25 s to promote early intervention beginning in school age.
26 sensitization increase the risk of asthma at school age.
27 in is rarely seen in youth before they reach school age.
28 terns of 60 candidate genes in boys at early school age.
29 n assessment of neurodevelopment at least to school age.
30 3 at age 5 years or less predicted asthma at school age.
31 dogenous DHA synthesis in infancy but not at school-age.
32 nsitization (0.73 [0.56-0.96]) and asthma at school age (0.72 [0.55-0.95]).
33 , 0.36-0.43) and of not completing secondary school (age 2 years: 0.74, 0.67-0.78; mid-childhood: 0.8
34 s during infancy (0-2 yr) and again at early school age (4-8 yr).
35 ods, surveys of children entering elementary school (age 5 years before Sept 1) allow assessment of s
36 d for 6 wk, is an effective intervention for school-aged (5-10 y old) children with FASDs.
37                                           At school age, 51 of 68 children were followed up, and 15 (
38  A total of 402 children were followed until school age (6-11 years) for the assessment of current at
39 d 31 weeks postpartum (infants), and once at school age (6-11 years), from 440 children (49.3% girls,
40  assessed with MRI in these same children at school age (7-12 years old).
41                                 Thirty-eight school-age (8-12 yr) survivors of neonatal extracorporea
42 sociation between transient hypoglycemia and school-age achievement test proficiency based on perinat
43 as via a toddler (aged 1 to <3 years-old) or school-aged (aged 6 to <12 years-old) co-occupant.
44  or functional outcomes in their children at school age, although a mortality advantage cannot be exc
45 predicts the probability of having asthma at school age among preschool children with suggestive symp
46 sterone, DHEA, and hippocampal volume across school age and adolescence, and measures of emotion regu
47                          Additional study at school age and beyond would be informative.
48 measured using magnetic resonance imaging at school age and children's diagnosis of MDD any time afte
49  support on hippocampal volume growth across school age and early adolescence and suggest an early ch
50  of magnetic resonance brain imaging through school age and early adolescence.
51  of cortical gray matter development in late school age and early adolescence.
52 diagnostic outcomes of preschool children at school age and in adolescence.
53 early childhood impacts brain development at school age and to explore the mediators of this effect.
54 ing multiplex array among 509 adults and 140 school-age and 131 preschool children with asthma/wheeze
55 was assembled in 1978-79, and followed up at school-age and adulthood.
56 t, notably physical activity, need to target school-aged and possibly younger children.
57 ze and cough at 2 time points (preschool and school age) and objective measurements of atopy, lung fu
58 titis was found in 50% of those diagnosed in school age, and persistent atopic dermatitis was signifi
59 atric population including neonate, toddler, school-aged, and adolescents.
60 uals; however, those arriving during primary school ages appeared especially vulnerable.
61 tors associated with respiratory symptoms at school age are early respiratory problems, family histor
62 greater negative mood/depression severity at school age, as did connectivity between the left hippoca
63 ercury exposure with poorer performance on a school-age assessment of IQ, a measure whose relevance f
64  risks of preschool wheezing (1-4 years) and school-age asthma (5-10 years).
65 uramic acid related to a lower prevalence of school-age asthma (adjusted odds ratio, 0.59 [95% confid
66  with higher risks of preschool wheezing and school-age asthma (P < .05).
67  wheezing (pOR, 1.10; 95% CI, 1.00-1.21) and school-age asthma (pOR, 1.13; 95% CI, 1.01-1.27).
68 ds ratio [pOR], 1.34; 95% CI, 1.25-1.43) and school-age asthma (pOR, 1.40; 95% CI, 1.18-1.67) indepen
69 eight gain, we observed the highest risks of school-age asthma in children born preterm with high inf
70 we performed epigenome-wide meta-analyses of school-age asthma in relation to CpG methylation (Illumi
71 d FeNO is associated with increased risk for school-age asthma.
72 onfirmed wheeze by age 3 years, 117(35%) had school-age asthma.
73 of characteristics at age 3 years to predict school-age asthma.
74  This yielded prevalence estimates for FA in school age between 1.4% (88 related to all 6105 particip
75 xis with hypoallergenic cochineal onset in a school-age boy.
76 omen, with or without routine vaccination of school-age boys, and for a 1-time catch-up vaccination o
77                               Among the 1676 school-aged cases, 1536 (92%) had previously received at
78                   Given the magnitude of the school-aged child population, a sizeable proportion of i
79 of task-irrelevant VPL in healthy elementary school age children (7-10 years old) and compared their
80 group (p=.04) based on self-report scores in school age children and adolescents.
81                Screening of lung function in school age children may identify a high-risk group that
82 A from mattress dust and nasal samples of 86 school age children was analyzed by 454 pyrosequencing o
83                                          The school age children with JCP can express their symptom a
84  behavioral condition which affects 2-10% of school age children worldwide.
85 toddlers, 34(19.7%) preschool and 65 (37.6%) school age children, and 39 (22.5%) adolescents.
86  Infection prevalence and intensity peaks in school age children: both reduced water contact and acqu
87 wth standards" and "WHO growth standards for school aged children and adolescents" for children up to
88 ication method ranged from 18.9% to 36.9% in school-age children (5-11 years) and from 16.6% to 35.8%
89 ncentrations among infants (6-23 mo of age), school-age children (6-8 y of age), and women (15-25 y o
90  39 preschool children (ages 3-6 yr), and 38 school-age children (7-16 yr) with CF before chest compu
91 nce imaging was completed on a subset of 145 school-age children (age range, 6.11-12.11 years).
92 he nutrition of preprimary and early primary school-age children also merit consideration.
93 r study was to evaluate the iodine intake of school-age children and adolescents, using UIE measureme
94 y greatly across subgroups, being highest in school-age children and adults (18.3%, CI 9.4%-28.2%, an
95  2009 pandemic could have a modest impact on school-age children and adults in terms of IPD and a sma
96 or Affective Disorders and Schizophrenia for School-Age Children and functioning assessed by the Chil
97  cause of respiratory disease, especially in school-age children and young adults.
98           Inclusion criteria were studies of school-age children between 6 and 19 years.
99                                              School-age children born preterm are particularly at ris
100 d on 3 bilateral basal ganglia structures in school-age children chronically exposed to Mn through dr
101 ic vaccination campaign targeting adults and school-age children could have mitigated or prevented th
102  for the obstructive sleep apnea syndrome in school-age children did not significantly improve attent
103 sylation was analysed in serum/plasma of 700 school-age children from different communities of Gabon,
104                           In both adults and school-age children from the general population, reporti
105                      IQ was estimated in 282 school-age children from whom umbilical cord blood sampl
106  exposure on various respiratory outcomes in school-age children generally representative of the popu
107  a panel study in a representative sample of school-age children in the two major cities of Greece, A
108 his study, blood samples were collected from school-age children in Western Kenya, in the form of bot
109 he findings underline the critical role that school-age children play in facilitating the geographic
110 or Affective Disorders and Schizophrenia for School-Age Children Present and Lifetime version (K-SADS
111 d with children without a history of PO MDD, school-age children previously diagnosed as having PO MD
112 iod either amongst study children or amongst school-age children resident in the study areas.
113 on or P. falciparum infection in infants and school-age children resulted in significantly lower ID p
114 ms of the study were to assess chronotype in school-age children using a novel integrative measuremen
115                                              School-age children were enrolled in the Southern Califo
116 rker and either MUIC or goiter prevalence in school-age children were included.
117   This is a retrospective study of sixty-six school-age children who received overnight orthokeratolo
118 ical and vascular foveal structures in early school-age children who were born premature were differe
119 imed to examine patterns of dysconnection in school-age children with ASD and ADHD and typically deve
120 tor structural lung disease in preschool and school-age children with CF.
121 tion was significantly higher in infants and school-age children with either inflammation or P. falci
122 order (ADHD) is estimated to affect 8-12% of school-age children worldwide.
123 inth infections with micronutrient status in school-age children worldwide.
124 e purpose of the current study was to assess school-age children's multitasking abilities during degr
125  and household levels in children aged <5 y, school-age children, adolescents, and adults.
126 dren younger than 5 years, 22.2-25.9 million school-age children, and 16.5-21.1 million adolescents w
127                                           In school-age children, hookworm infection does not produce
128                       In Ivorian infants and school-age children, ID prevalence was considerably lowe
129                                           In school-age children, lung clearance index correlates wit
130                             In preschool and school-age children, lung clearance index has a good pos
131 district from 10% to 75% coverage of at-risk school-age children, the cost-effectiveness in terms of
132              In a population-based sample of school-age children, we investigated factors associated
133 or Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version intervi
134 mical contaminants with asthma and eczema in school-age children.
135    Bullying is a pervasive problem affecting school-age children.
136 en helminth infections and micronutrients in school-age children.
137 s individual differences in the behaviors of school-age children.
138 ificantly more than that of non-TCM users in school-age children.
139 ion, and cognition in the CHAMACOS cohort of school-age children.
140 C) <100 ug/L, or >5% prevalence of goiter in school-age children.
141  [0.5%] exposed to farm animals) and 276,298 school-aged children (22,629 [8.2%] exposed to dogs and
142 the highest prevalence of schistosomiasis in school-aged children (52.8%, 95% CrI 48.7-57.8).
143 st effective compared with treatment of only school-aged children (ICER $167 per DALY averted) and WH
144 ssociated with a decreased risk of asthma in school-aged children (OR, 0.87; 95% CI, 0.81-0.93) and i
145                                              School-aged children (SAC) carry a disproportionate burd
146 he neuropsychological functioning of healthy school-aged children after an overnight fast.
147 of antimalarial treatment among asymptomatic school-aged children aged 5-15 years in sub-Saharan Afri
148 alaria infection in sub-Saharan Africa among school-aged children aged 5-15 years is underappreciated
149 reatment costs were estimated at US$0.74 for school-aged children and $1.74 for preschool-aged childr
150                In the United States, 4 of 10 school-aged children and 1 of 3 adolescents are involunt
151 ion (95% CrI 121 million to 125 million) for school-aged children and 247 million (239 million to 256
152 sentially uncharted, and existing studies in school-aged children and adolescents are confounded grea
153  brief counseling, to prevent tobacco use in school-aged children and adolescents have a moderate net
154 re interventions for tobacco cessation among school-aged children and adolescents who already smoke,
155               This recommendation applies to school-aged children and adolescents younger than 18 yea
156 , to prevent initiation of tobacco use among school-aged children and adolescents.
157               This recommendation applies to school-aged children and adolescents.
158 ing, to prevent initiation of tobacco use in school-aged children and adolescents.
159 tions for the cessation of tobacco use among school-aged children and adolescents.
160 rs of reading skills have been identified in school-aged children and adults; many pertain to the pre
161 rrent diagnosis of asthma at age 6 years for school-aged children and as the hazard ratio (HR) for in
162                            CD affects ~3% of school-aged children and is twice as prevalent in males
163 ducing P falciparum infection and anaemia in school-aged children and lowering parasite transmission.
164 ciated with a reduced risk of asthma in both school-aged children and preschool-aged children (OR, 0.
165 h 75% coverage in only school-aged children; school-aged children and preschool-aged children; adults
166  life circumstances of a community sample of school-aged children and then followed these children fo
167 y rate relative to baseline were greatest in school-aged children and young adults, with no evidence
168 is was highly cost-effective in treatment of school-aged children at a prevalence of 20% (95% UI 5.4-
169 is was highly cost-effective in treatment of school-aged children at a prevalence threshold of 5% (95
170 e helpful in providing the time to vaccinate school-aged children before the pandemic peaks.
171                      Improving the health of school-aged children can yield substantial benefits for
172                                  Vaccinating school-aged children cost $718-$1849/case averted (<=$50
173 or socioeconomic status (Health Behaviour in School-aged Children Family Affluence Scale) and health
174          Weekly volunteering with elementary school-aged children for 2 months vs wait-list control g
175  It is estimated that vaccinating 50%-70% of school-aged children for influenza can produce populatio
176 kworm, A lumbricoides, and T trichiura among school-aged children from 2000 onwards was 16.5%, 6.6%,
177 ross-sectional survey was carried out on 693 school-aged children from 5 schistosomiasis-endemic vill
178 cted from 4512 ethnically diverse, nonmyopic school-aged children from grades 1 through 8 (baseline g
179 research summer camp program for low-income, school-aged children from July 1, 1986, to August 15, 20
180                         For unknown reasons, school-aged children have substantially higher infection
181 e included in the differential diagnosis for school-aged children hospitalized with CAP.
182 ffective in reducing BMI z scores in primary-school-aged children in China.
183 ysis sheds quantitative light on the role of school-aged children in measles cross-scale dynamics, as
184 l exposure samples (n = 249) of 62 asthmatic school-aged children in Montreal were collected over 10
185                      In a 5-year study among school-aged children in Pittsburgh, Pennsylvania, pharyn
186 ssure measurements and myopia progression in school-aged children in Taiwan.
187           The stable overall suicide rate in school-aged children in the United States during 20 year
188                          Recommendations for school-aged children include 60 minutes of daily moderat
189 transmitted helminthiasis when prevalence in school-aged children is at or above a threshold of 50% a
190         Low-risk countries (prevalence among school-aged children lower than 10%) included Burundi, E
191 he basis of WHO guidelines (treatment of all school-aged children once per year where prevalence in t
192                          For households with school-aged children only (no children 0-5 years), IC ha
193        Preventive treatment of malaria among school-aged children significantly decreases P falciparu
194                        Second to their home, school-aged children spend the largest portion of their
195 nalysis of data from the Health Behaviour in School-aged Children study, in which cross-sectional sur
196 is associated with allergic sensitization in school-aged children suggesting systemic low-grade infla
197 rtance of regular screening of preschool and school-aged children to reduce the development and progr
198 tinuum in a large population-based sample of school-aged children were found.
199  cRCT in closely connected communities where school-aged children were vaccinated: 60% (95% confidenc
200 to improved adherence and asthma outcomes in school-aged children who presented to the emergency depa
201 iles of 655 participants (n = 601 adults and school-aged children with asthma and 54 preschool childr
202 s in adherence to inhaled corticosteroids in school-aged children with asthma.
203  Inner-City Asthma Study (n = 350) recruited school-aged children with asthma.
204       Ocular signs appear in roughly half of school-aged children with Fabry disease and are well-rec
205                                  Vaccinating school-aged children with LAIV is likely to be cost-effe
206 tion concentrated on a small area, including school-aged children with low background incidence of ca
207    Suicide is a leading cause of death among school-aged children younger than 12 years but little is
208                                       In the school-aged children's cohort, 11,585 children (4.2%) ex
209                                        Among school-aged children, 0.1% were classified as stunted an
210 t included 17,696 children aged <5 y, 25,508 school-aged children, 28,328 adolescents, 89,164 adults,
211 udies were, however, performed in adults and school-aged children, and only a little is known about h
212  and individual levels in children <5 y old, school-aged children, and women of reproductive age.
213 doses against hookworm infections in African school-aged children, key information for the developmen
214 iciency was found in 2.8%, 0.7%, and 8.4% of school-aged children, respectively.
215  classification rules for identifying CRS in school-aged children, using laboratory biomarkers.
216  parasitic infections emphasise treatment of school-aged children, using separate treatment guideline
217       Guidelines can be improved by sampling school-aged children, which also is operationally more f
218                                  Notably, AC school-aged children, who comprise 5% of the population,
219 ers, counterintuitively, perform better than school-aged children, who in turn perform better than ad
220 Zika vaccination (women of childbearing age, school-aged children, young adults, and everyone) and th
221 athematics and science courses to their high-school-aged children.
222 ensive custom-made spectacles among eligible school-aged children.
223  (Feno), and risks of wheezing and asthma in school-aged children.
224 on neuropsychological functioning in healthy school-aged children.
225 f regulatory molecules was undertaken in 121 school-aged children.
226 sitemia was high across all ages, peaking in school-aged children.
227 d monitoring strategies that mainly focus on school-aged children.
228 e of asthenopia in unselected populations of school-aged children.
229 adults were ten times greater than those for school-aged children.
230 cy and diagnosis of a learning disability in school-aged children.
231 pregnancy with kidney volume and function in school-aged children.
232 ociated with asthma phenotypes in inner-city school-aged children.
233 al and infant growth with kidney function in school-aged children.
234 aily television exposure among preschool and school-aged children.
235 modulated noise) static gratings develops in school-aged children.
236 th subclinical changes in kidney outcomes in school-aged children.
237 ms can efficiently immunize large numbers of school-aged children.
238  reinfection were observed in this sample of school-aged children.
239 (WSH) with administration of praziquantel to school-aged children.
240 rospective analyses, or cross-sectionally in school-aged children.
241 rder cognitive networks, are present even in school-aged children.
242 mework to prevent obesity in Chinese primary-school-aged children.
243 y of asthma and wheeze between preschool and school-aged children.
244 onal connectivity is associated with PLEs in school-aged children.
245 curately classify-atopy and atopic asthma in school-aged children.
246 on between gestational age and 4 outcomes in school-aged children: readiness to enter kindergarten, s
247 reatment programme with 75% coverage in only school-aged children; school-aged children and preschool
248 th adverse neurodevelopmental outcomes among school-aged children; yet, few studies have evaluated pr
249 In countries with no pertussis booster until school age, continued monitoring of protection against p
250 rvivors available for follow-up, outcomes at school age (corrected age 6-11 years) were determined fo
251 f depression participated in neuroimaging at school age/early adolescence.
252 l connectivity in a well-controlled group of school-aged EPT children with no known brain injury or n
253                      Children with asthma by school age exhibited an aberrant immune response to path
254 iota of 327 throat and 68 nasal samples from school-age farm and nonfarm children were analyzed by 45
255 s isolated from a PEODDN lesion of a primary school-aged female patient with bands of hyperkeratotic-
256  total of 6105 children participated in this school-age follow-up (57.8% of 10 563 recruited at birth
257  from the 14 centers who participated in the school-age follow-up (n = 443 magnesium; n = 424 placebo
258 hood materially impacts brain development at school age further underscores the importance of attenti
259 gnetic resonance imaging (fMRI) data from 68 school-aged girls, along with social network information
260 antly increased risk of developing asthma by school age (&gt;/=2 biomarkers vs none: OR, 6.6; 95% CI, 2.
261 n early childhood, although its effects into school age have not been reported from randomized trials
262  increase maternal HIV-disclosure to primary school-aged HIV-uninfected children.
263 has never evaluated in children cases around school age in ENT out-patient clinic.
264 il thickening and plantar keratoderma before school age in more than three-quarters of affected child
265 ple and robust tool for predicting asthma at school age in preschool children with wheeze or cough.
266 d gut microbiota development from infancy to school age in relation to onset of IgE-associated allerg
267 mpus and amygdala and a number of regions at school age, including the superior frontal cortex, lingu
268 p < 0.001) in 2017-2018 among non-elementary-school-aged individuals and -73 (95% CI -147, 1; p = 0.0
269 ation between mode of delivery and asthma at school age is inconclusive.
270                                           At school age, many new Actinobacteria, Firmicutes, and Bac
271 vel modeling of the effects of preschool and school-age maternal support on hippocampal volumes acros
272              Higher TAC of the diet in early school age may decrease the risk of developing sensitiza
273 uring pregnancy, cord blood, and children at school age (median age, 7.7 years; interquartile range,
274 rdized interviews in those children reaching school age (n = 166).
275 .001, n = 618) and reduced risk of asthma at school age (odds ratio (OR) = 0.72 (0.56-0.93), P = 0.01
276 0% reduced odds of ever allergic rhinitis at school age (odds ratios of 0.79 [95% CI, 0.67-0.92] and
277 set remitting, midchildhood-onset remitting, school age-onset persisting, late childhood-onset persis
278 mergency departments (EDs) and to those high school age or older.
279 tion in childhood protects against asthma at school age partially by means of higher intake of omega-
280                                    Adult and school-age participants in the standardized EuroPrevall
281  smaller, suggesting exposures at elementary school age play a greater role in this population.
282 ng >=3 were at high risk of having asthma at school-age (PPV > 75%; +LR 6.3, -LR 0.6), whereas childr
283                       The study included 320 school-aged subjects with caregiver-reported IPV in the
284                                 No effect of school-age support was found.
285 rrelates of attention and memory deficits in school-age survivors of neonatal extracorporeal membrane
286 was inversely associated with HT; c-BMI from school age to adulthood and c-height from birth to schoo
287 live at randomization, the mortality rate to school age was 14% (88/629) in the magnesium sulfate gro
288 leanliness and allergic health conditions at school age was collected in 399 participants of the urba
289                             Alveolar size at school age was similar in survivors of extreme prematuri
290                        Asthma at 8/11 years (school-age) was defined as parentally reported (a) physi
291 tal IgE level, and allergen sensitization at school age were conducted.
292  age to adulthood and c-height from birth to school age were positively associated with hypertension.
293 children who participated in neuroimaging at school age were used to investigate the effects of pover
294 regnant mothers, cord blood, and children at school age were weak to moderate (r = -0.03 to 0.53).
295 tive biomarkers of anxiety are needed before school age when anxiety symptoms typically consolidate i
296          That is especially relevant towards school age when children need top-down control to solve
297 n impact on functional brain connectivity at school age, which in turn mediates influences on child n
298 easures of respiratory/allergic morbidity at school age, while children breastfed for at least 3 mont
299 mation develops, particularly throughout the school-aged years.
300 ing two-week science summer camps for middle-school-aged youth.

 
Page Top